These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 38285284

  • 1. A first-in-man study of [18F] FEDAC: a novel PET tracer for the 18-kDa translocator protein.
    Tamura K, Nishii R, Tani K, Hashimoto H, Kawamura K, Zhang MR, Maeda T, Yamazaki K, Higashi T, Jinzaki M.
    Ann Nucl Med; 2024 Apr; 38(4):264-271. PubMed ID: 38285284
    [Abstract] [Full Text] [Related]

  • 2. Visualization of acute liver damage induced by cycloheximide in rats using PET with [(18)F]FEDAC, a radiotracer for translocator protein (18 kDa).
    Hatori A, Yui J, Xie L, Yamasaki T, Kumata K, Fujinaga M, Wakizaka H, Ogawa M, Nengaki N, Kawamura K, Zhang MR.
    PLoS One; 2014 Apr; 9(1):e86625. PubMed ID: 24466178
    [Abstract] [Full Text] [Related]

  • 3. 18F-FEAC and 18F-FEDAC: PET of the monkey brain and imaging of translocator protein (18 kDa) in the infarcted rat brain.
    Yui J, Maeda J, Kumata K, Kawamura K, Yanamoto K, Hatori A, Yamasaki T, Nengaki N, Higuchi M, Zhang MR.
    J Nucl Med; 2010 Aug; 51(8):1301-9. PubMed ID: 20660373
    [Abstract] [Full Text] [Related]

  • 4. Radiation dosimetry and biodistribution of the translocator protein radiotracer [(11)C]DAA1106 determined with PET/CT in healthy human volunteers.
    Brody AL, Okita K, Shieh J, Liang L, Hubert R, Mamoun M, Farahi J, Mandelkern MA.
    Nucl Med Biol; 2014 Aug; 41(10):871-5. PubMed ID: 25156039
    [Abstract] [Full Text] [Related]

  • 5. In vivo imaging and quantitative analysis of TSPO in rat peripheral tissues using small-animal PET with [18F]FEDAC.
    Yanamoto K, Kumata K, Fujinaga M, Nengaki N, Takei M, Wakizaka H, Hosoi R, Momosaki S, Yamasaki T, Yui J, Kawamura K, Hatori A, Inoue O, Zhang MR.
    Nucl Med Biol; 2010 Oct; 37(7):853-60. PubMed ID: 20870161
    [Abstract] [Full Text] [Related]

  • 6. 18F-FPYBF-2, a new F-18 labelled amyloid imaging PET tracer: biodistribution and radiation dosimetry assessment of first-in-man 18F-FPYBF-2 PET imaging.
    Nishii R, Higashi T, Kagawa S, Okuyama C, Kishibe Y, Takahashi M, Okina T, Suzuki N, Hasegawa H, Nagahama Y, Ishizu K, Oishi N, Kimura H, Watanabe H, Ono M, Saji H, Yamauchi H.
    Ann Nucl Med; 2018 May; 32(4):256-263. PubMed ID: 29453681
    [Abstract] [Full Text] [Related]

  • 7. PET imaging of lung inflammation with [18F]FEDAC, a radioligand for translocator protein (18 kDa).
    Hatori A, Yui J, Yamasaki T, Xie L, Kumata K, Fujinaga M, Yoshida Y, Ogawa M, Nengaki N, Kawamura K, Fukumura T, Zhang MR.
    PLoS One; 2012 May; 7(9):e45065. PubMed ID: 22984611
    [Abstract] [Full Text] [Related]

  • 8. Biodistribution and Radiation Dosimetry for the Novel SV2A Radiotracer [(18)F]UCB-H: First-in-Human Study.
    Bretin F, Bahri MA, Bernard C, Warnock G, Aerts J, Mestdagh N, Buchanan T, Otoul C, Koestler F, Mievis F, Giacomelli F, Degueldre C, Hustinx R, Luxen A, Seret A, Plenevaux A, Salmon E.
    Mol Imaging Biol; 2015 Aug; 17(4):557-64. PubMed ID: 25595813
    [Abstract] [Full Text] [Related]

  • 9. Biodistribution and radiation dosimetry of the integrin marker 18F-RGD-K5 determined from whole-body PET/CT in monkeys and humans.
    Doss M, Kolb HC, Zhang JJ, Bélanger MJ, Stubbs JB, Stabin MG, Hostetler ED, Alpaugh RK, von Mehren M, Walsh JC, Haka M, Mocharla VP, Yu JQ.
    J Nucl Med; 2012 May; 53(5):787-95. PubMed ID: 22499613
    [Abstract] [Full Text] [Related]

  • 10. Utility of Translocator Protein (18 kDa) as a Molecular Imaging Biomarker to Monitor the Progression of Liver Fibrosis.
    Hatori A, Yui J, Xie L, Kumata K, Yamasaki T, Fujinaga M, Wakizaka H, Ogawa M, Nengaki N, Kawamura K, Wang F, Zhang MR.
    Sci Rep; 2015 Nov 27; 5():17327. PubMed ID: 26612465
    [Abstract] [Full Text] [Related]

  • 11. Biodistribution and radiation dosimetry of 18F-CP-18, a potential apoptosis imaging agent, as determined from PET/CT scans in healthy volunteers.
    Doss M, Kolb HC, Walsh JC, Mocharla V, Fan H, Chaudhary A, Zhu Z, Alpaugh RK, Lango MN, Yu JQ.
    J Nucl Med; 2013 Dec 27; 54(12):2087-92. PubMed ID: 24136934
    [Abstract] [Full Text] [Related]

  • 12. Whole body biodistribution and radiation dosimetry in humans of a new PET ligand, [(18)F]-FEPPA, to image translocator protein (18 kDa).
    Mizrahi R, Rusjan PM, Vitcu I, Ng A, Wilson AA, Houle S, Bloomfield PM.
    Mol Imaging Biol; 2013 Jun 27; 15(3):353-9. PubMed ID: 22895910
    [Abstract] [Full Text] [Related]

  • 13. 18F-ICMT-11, a caspase-3-specific PET tracer for apoptosis: biodistribution and radiation dosimetry.
    Challapalli A, Kenny LM, Hallett WA, Kozlowski K, Tomasi G, Gudi M, Al-Nahhas A, Coombes RC, Aboagye EO.
    J Nucl Med; 2013 Sep 27; 54(9):1551-6. PubMed ID: 23949910
    [Abstract] [Full Text] [Related]

  • 14. [18F]FEDAC translocator protein positron emission tomography-computed tomography for early detection of mitochondrial dysfunction secondary to myocardial ischemia.
    Luo R, Wang L, Ye F, Wang YR, Fang W, Zhang MR, Wang F.
    Ann Nucl Med; 2021 Aug 27; 35(8):927-936. PubMed ID: 34081287
    [Abstract] [Full Text] [Related]

  • 15. Quantitative assessment of translocator protein (TSPO) in the non-human primate brain and clinical translation of [18F]LW223 as a TSPO-targeted PET radioligand.
    Tan Z, Haider A, Zhang S, Chen J, Wei J, Liao K, Li G, Wei H, Dong C, Ran W, Li Y, Li Y, Rong J, Li Y, Liang SH, Xu H, Wang L.
    Pharmacol Res; 2023 Mar 27; 189():106681. PubMed ID: 36746361
    [Abstract] [Full Text] [Related]

  • 16. Biodistribution and radiation dosimetry of deuterium-substituted 18F-fluoromethyl-[1, 2-2H4]choline in healthy volunteers.
    Challapalli A, Sharma R, Hallett WA, Kozlowski K, Carroll L, Brickute D, Twyman F, Al-Nahhas A, Aboagye EO.
    J Nucl Med; 2014 Feb 27; 55(2):256-63. PubMed ID: 24492392
    [Abstract] [Full Text] [Related]

  • 17. 18F-FEDAC as a Targeting Agent for Activated Macrophages in DBA/1 Mice with Collagen-Induced Arthritis: Comparison with 18F-FDG.
    Chung SJ, Yoon HJ, Youn H, Kim MJ, Lee YS, Jeong JM, Chung JK, Kang KW, Xie L, Zhang MR, Cheon GJ.
    J Nucl Med; 2018 May 27; 59(5):839-845. PubMed ID: 29326355
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Whole-body biodistribution kinetics, metabolism, and radiation dosimetry estimates of 18F-PEG6-IPQA in nonhuman primates.
    Tian M, Ogawa K, Wendt R, Mukhopadhyay U, Balatoni J, Fukumitsu N, Uthamanthil R, Borne A, Brammer D, Jackson J, Mawlawi O, Yang B, Alauddin MM, Gelovani JG.
    J Nucl Med; 2011 Jun 27; 52(6):934-41. PubMed ID: 21571803
    [Abstract] [Full Text] [Related]

  • 20. Preclinical Incorporation Dosimetry of [18F]FACH-A Novel 18F-Labeled MCT1/MCT4 Lactate Transporter Inhibitor for Imaging Cancer Metabolism with PET.
    Sattler B, Kranz M, Wenzel B, Jain NT, Moldovan RP, Toussaint M, Deuther-Conrad W, Ludwig FA, Teodoro R, Sattler T, Sadeghzadeh M, Sabri O, Brust P.
    Molecules; 2020 Apr 26; 25(9):. PubMed ID: 32357571
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.